October 15, 2021
Pfizer Japan, Mylan Seiyaku, and Viatris Pharmaceuticals Japan will discontinue 18 generic drugs (APIs)/32 products including the antibiotic Tazopipe (piperacillin + tazobactam) and the sleep inducer zolpidem. They will be delisted after a transition period that will last through the...read more